In December of 2021, the FDA lifted some of its burdensome restrictions on the abortion pill mifepristone, including the requirement that healthcare providers must meet in-person with patients to dispense the medication. Nineteen states, however, continue to impose in-person dispensing requirements.
Legal scholars and advocates are questioning the constitutionality of these additional restrictions on abortion pills.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed